Skip to main content
Hit enter to search or ESC to close
Safety and efficacy of eptinezumab for migraine prevention in patients with two-to-four previous preventive treatment failures (DELIVER): a multi-arm, randomised, double-blind, placebo-controlled, phase 3b trial
© 2024 VHIR Annual Report 2022.
Data protection policy
Facts & Figures
Partners and Acknowledgements
VHIR Annual Report 2022